Miglustat
- Product NDC
- 42799-708
- 11-digit product format
- 427990708
- Labeler code
- 42799
- Product ID
- 42799-708_21af69ea-298f-4c2c-8604-75a612eb85e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Miglustat
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Edenbridge Pharmaceuticals LLC.
- Application
- ANDA209821
- Marketing category
- ANDA
- Marketing start
- 2020-08-06
- Marketing end
- 0000-00-00
- Substance
- MIGLUSTAT
- Active strength
- 100 mg/1
- Pharmacologic classes
- Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42799-708-01 | 42799070801 | 6 BLISTER PACK in 1 CARTON (42799-708-01) > 15 CAPSULE in 1 BLISTER PACK | 6 blister pack | 2020-08-06 | 0000-00-00 | No | No | Current |
| 42799-708-15 | 42799070815 | 1 BLISTER PACK in 1 CARTON (42799-708-15) > 15 CAPSULE in 1 BLISTER PACK | 1 blister pack | 2020-08-06 | 0000-00-00 | No | No | Current |